Drug – bio-affecting and body treating compositions – Radionuclide or intended radionuclide containing; adjuvant...
Patent
1983-04-25
1986-10-07
Nucker, Christine M.
Drug, bio-affecting and body treating compositions
Radionuclide or intended radionuclide containing; adjuvant...
424 9, 534 14, A61K 4300, A61K 4900
Patent
active
046158766
ABSTRACT:
Stable neutral-lipophilic complexes of technetium-99m (Tc-99m) useful as diagnostic radionuclidic imaging agents are formed by complexing technetium-99m pertechnetate with alkylene amine oximes (viz. propylene amine oxime) in aqueous solutions under reducing conditions. The complexes have a zero charge, contain an O--H--O ring closure bond, and are sufficiently stable for parental administration in imaging by scintillation scanning. Substituents can be attached to the C.sub.2 to C.sub.4 alkylene carbon backbone of the tetradentate amine oxime ligands to structurally modify them and produce a variety of Tc-99m-radiopharmaceuticals with specific body imaging applications.
REFERENCES:
patent: 4352751 (1982-10-01), Wieder et al.
patent: 4360511 (1982-11-01), Baldwin et al.
patent: 4363793 (1982-12-01), Blau et al.
Karesh et al, J. Pharmaceutical Sciences, 66 (1977) 225-8.
Eckelman et al. J. Pharmaceutical Sciences, 64 (1975) 704-6.
Troutner David E.
Volkert Wynn A.
Curators of the University of Missouri
Nucker Christine M.
LandOfFree
Macrocyclic complexes of technetium-99m for use as diagnostic ra does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Macrocyclic complexes of technetium-99m for use as diagnostic ra, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Macrocyclic complexes of technetium-99m for use as diagnostic ra will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-642365